Johnson and Johnson’s vaccine is 66% effective against moderate to severe COVID-19

The vaccine’s efficacy was highest in the U.S. and the lowest in South Africa, where a new variant is infecting people.

The post Johnson and Johnson’s vaccine is 66% effective against moderate to severe COVID-19 appeared first on Scout SEO- Melbourne Internet Marketing.

from Innovation and Digital Marketing https://www.livescience.com/johnson-and-johnson-coronavirus-vaccine-effective-severe-disease.html?utm_source=rss&utm_medium=rss